{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:03:35Z","timestamp":1791594215230,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jaci.2017.08.040","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T15:01:11Z","timestamp":1509116471000},"page":"2142-2155.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations"],"prefix":"10.1016","volume":"141","author":[{"given":"Alexander","family":"Vargas-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa S.","family":"Zerbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-2214","authenticated-orcid":false,"given":"Edith","family":"Schussler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan K.","family":"Chinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-2205","authenticated-orcid":false,"given":"Alexandre F.","family":"Carisey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda C.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-1934","authenticated-orcid":false,"given":"Lisa R.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2017.08.040_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib4","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2017.08.040_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","article-title":"A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells","volume":"22","author":"Freud","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2017.08.040_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","article-title":"Human natural killer cell development","volume":"214","author":"Freud","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2017.08.040_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cellbi.2007.08.025","article-title":"Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs","volume":"32","author":"Fan","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jaci.2017.08.040_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.imbio.2007.10.012","article-title":"New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles","volume":"213","author":"Wilk","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2017.08.040_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.20052507","article-title":"Evidence for discrete stages of human natural killer cell differentiation in\u00a0vivo","volume":"203","author":"Freud","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib11","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2006-04-020198","article-title":"Coordinated acquisition of inhibitory and activating receptors and functional\u00a0properties by developing human natural killer cells","volume":"108","author":"Grzywacz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.161.1.400","article-title":"Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets","volume":"161","author":"Frey","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V98.3.705","article-title":"Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2\/L3\/S2","volume":"98","author":"Miller","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib14","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.200324533","article-title":"IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors","volume":"33","author":"Sivori","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2009-04-215491","article-title":"CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets","volume":"115","author":"Yu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib16","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bjorkstrom","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2567.2005.02235.x","article-title":"Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity","volume":"116","author":"Addison","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2017.08.040_bib18","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verges","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2013.00055","article-title":"Epigenetic regulation of NK cell differentiation and effector functions","volume":"4","author":"Cichocki","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in\u00a0vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib22","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1073\/pnas.1405514111","article-title":"IL-15.IL-15Ralpha complex shedding following trans-presentation is essential\u00a0for the survival of IL-15 responding NK and T cells","volume":"111","author":"Tamzalit","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.08.040_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fimmu.2016.00545","article-title":"Genetic causes of human NK cell deficiency and their effect on NK cell subsets","volume":"7","author":"Mace","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1172\/JCI86276","article-title":"Biallelic mutations in IRF8 impair human NK cell maturation and function","volume":"127","author":"Mace","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2017.08.040_bib25","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI61014","article-title":"Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency","volume":"122","author":"Gineau","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2017.08.040_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI60224","article-title":"MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans","volume":"122","author":"Hughes","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2017.08.040_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nri2381","article-title":"Formation and function of the lytic NK-cell immunological synapse","volume":"8","author":"Orange","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib30","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2017.08.040_bib31","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2016.10.051","article-title":"Impaired NK cell functions in patients with STAT1 gain-of-function mutations","volume":"140","author":"Tabellini","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2017.08.040_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cytogfr.2007.06.021","article-title":"STAT dynamics","volume":"18","author":"Reich","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2017.08.040_bib37","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1073\/pnas.89.16.7836","article-title":"Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha","volume":"89","author":"Schindler","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.08.040_bib38","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1073\/pnas.89.23.11411","article-title":"Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor","volume":"89","author":"Gutch","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.08.040_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/1074-7613(95)90012-8","article-title":"Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process","volume":"2","author":"Greenlund","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2017.08.040_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib41","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1182\/blood.V86.12.4409.bloodjournal86124409","article-title":"Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells","volume":"86","author":"Tweardy","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib42","first-page":"694","article-title":"STATs in NK-cells: the good, the bad, and the ugly","volume":"7","author":"Gotthardt","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1084\/jem.190.9.1297","article-title":"Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers","volume":"190","author":"Zhang","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib44","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.4049\/jimmunol.162.5.2785","article-title":"Role of a STAT binding site in the regulation of the human perforin promoter","volume":"162","author":"Yu","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0006-291X(02)02378-1","article-title":"The human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells","volume":"297","author":"Yamamoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2017.08.040_bib46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","article-title":"Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity","volume":"188","author":"Imada","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.beem.2010.09.003","article-title":"STAT5b deficiency: lessons from STAT5b gene mutations","volume":"25","author":"Hwa","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2017.08.040_bib48","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.08.040_bib50","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.1200926","article-title":"Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain","volume":"189","author":"Takezaki","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib51","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","article-title":"Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis","volume":"131","author":"Sampaio","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib52","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0140-6736(12)60365-1","article-title":"Herpes in STAT1 gain-of-function mutation [corrected]","volume":"379","author":"Toth","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2017.08.040_bib53","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune\u00a0dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib54","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib55","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1073\/pnas.162376099","article-title":"Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses","volume":"99","author":"Orange","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.08.040_bib56","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2017.08.040_bib57","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4049\/jimmunol.134.3.1623","article-title":"TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)","volume":"134","author":"Yodoi","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib58","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","article-title":"Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency","volume":"119","author":"Shaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib61","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"Mossner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2017.08.040_bib62","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib63","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"Juelke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.08.040_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-016-8591-2","article-title":"An update on the use of immunomodulators in primary immunodeficiencies","volume":"52","author":"Vignesh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2017.08.040_bib66","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674917316470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674917316470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:09:13Z","timestamp":1758791353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674917316470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0091674917316470"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2017.08.040","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/157271","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2017.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}